Letícia S. C. da Silva

Letícia S. C. da Silva

Auto-generated profile, based on publicly available information

Letícia S. C. da Silva

Department of Ophthalmology, Universidade Federal de São Paulo, Sao Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Arquivos Brasileiros de Oftalmologia
Verified
Journal Article
Open access
LSLetícia S. C. da Silva
Letícia S. C. da Silva
LFLuciana P. S. Finamor
Luciana P. S. Finamor
GAGabriel Andrade
Gabriel Andrade
LLLuiz H. Lima
Luiz H. Lima
CZClaudio Zett
Claudio Zett
RJRubens Belfort Jr
Rubens Belfort Jr
The primary purpose of this study was to assess vascular retinal findings temporally related to COVID-19 vaccination. With greater information regarding all possible future adverse events, we hope to understand the real dimension and relevance of what was presented. Eleven patients with visual complaints after COVID-19 vaccination were enrolled. Data on the following were included: age, sex, vaccine, time of symptom onset, systemic findings, medical history, best-corrected visual acuity, and ocular findings by slit-lamp biomicroscopy as well as multimodal retinal imaging (color fundus, red-free photography, spectral-domain optical coherence tomography, optical coherence tomography angiography, and fluorescein-angiography). Inclusion criteria were the presence of ophthalmologic signs within 30 days after the first or second dose of any COVID-19 vaccine. Of 11 patients, five had arterial occlusion (45.4%), four had venous occlusion (36.4%), and two (18.2%) had nonspecific vascular alterations suggestive of retinal ischemia such as cotton-wool spots. The mean age was 57 (SD = 16; range: 27-84) years. The mean time of symptoms onset was 10 (SD = 5.4; range: 3-16) days. Nine patients were female (81.8%). Systemic risk factors were observed in 36.4% of patients. Two patients had both neurological and visual symptoms, with arterial occlusion. Overall, 36.4% patients had COVID-19 in the previous year. Seven patients (63.6%) received ChAdOx1 nCoV-19 (AZD1222) vaccine. Our data suggest that retinal events temporally related to COVID-19 vaccination are possible but are very rare. The relationship of these events with post-COVID-19 vaccination warrants further attention to derive a meaningful conclusion.

25 October 2022 in Ophthalmology Glaucoma
Verified
Journal Article
Closed access
ETElise V. Taniguchi
Elise V. Taniguchi
IAIzabela N.F. Almeida
Izabela N.F. Almeida
CGCarolina P.B. Gracitelli
Carolina P.B. Gracitelli
CACecília Agapito
Cecília Agapito
CZClaudio Zett
Claudio Zett
APAugusto Paranhos
Augusto Paranhos